Form 4: Inspire Medical Systems Executive Awarded Restricted Stock Units
SEC Form 4 Filing
Jason P. Kelly, Chief Manufacturing and Quality Officer at Inspire Medical Systems, received 4,541 restricted stock units on February 13, 2025, vesting in three equal annual installments starting February 13, 2026.
Summary
- Jason P. Kelly, Chief Manufacturing and Quality Officer of Inspire Medical Systems, was granted 4,541 restricted stock units on February 13, 2025.
- These restricted stock units vest in three equal annual installments, beginning on February 13, 2026.
- Each restricted stock unit represents the contingent right to receive one share of Inspire Medical Systems' common stock.
- Vesting is contingent upon Mr. Kelly's continuous employment with the company through the vesting dates.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. The granting of stock options is a standard practice and generally viewed favorably as it aligns management interests with shareholders.
Positives
- The granting of restricted stock units aligns the executive's interests with those of the shareholders.
- The vesting schedule encourages long-term commitment from the executive.
Risks
- The value of the restricted stock units is dependent on the future performance of Inspire Medical Systems' stock.
- If Jason P. Kelly leaves the company before the vesting dates, he will forfeit the unvested restricted stock units.
Future Outlook
The restricted stock units are subject to vesting based on continued employment, aligning executive compensation with long-term company performance.
Industry Context
Stock awards are a common form of executive compensation in the medical device industry, used to incentivize performance and retain key personnel.
Stakeholder Impact
- Shareholders may view the stock award positively as it incentivizes management to improve company performance.
- Employees may see the award as a sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 02/13/2025 | Date of transaction: Grant of 4,541 restricted stock units. |
| 02/13/2026 | First vesting date for the restricted stock units. |
| 02/24/2025 | Date of Form 4 filing. |
Keywords
restricted stock units, Inspire Medical Systems, Jason P. Kelly, stock award, executive compensation, Form 4, INSP
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.